Antigen-specific serotyping of Neisseria gonorrhoeae: characterization based upon principal outer membrane protein.

Infection and Immunity
T M Buchanan, J F Hildebrandt

Abstract

Principal outer membrane protein (protein I) of Neisseria gonorrhoeae was prepared nearly free of lipopolysaccharide (LPS) and substantially purified from other membrane proteins by chromatography of partially purified gonococcal outer membranes over Sepharose 6B in the presence of deoxycholate at pH 9.0. This protein I of nine separate antigenic types was coated to polystyrene tubes and used in the enzyme-linked immunosorbent assay (ELISA) to measure antibody to protein I or in inhibition tests to quantitate protein I antigen. No significant inhibition of the ELISA test was produced by purified LPS from the strain used to prepare each of the protein I types or by whole gonococci bearing the same LPS but different protein I antigens as the strain used to produce a given protein I antigen. Of 125 strains of gonococci used as whole organisms to inhibit the protein I ELISA, 124 (99%) typed with one or more of the nine protein I types, and 35% of these typed with a single protein I serotype. Sixty-one of 65 (94%) strains from Seattle and Atlanta patients with disseminated gonococcal infection contained protein I serotype 1, and 16 of 24 (64%) strains from Seattle patients with salpingitis bore one or both of protein I serotypes 1 a...Continue Reading

References

Jul 1, 1975·Journal of General Microbiology·P Novotny, W H Turner
Oct 1, 1977·Infection and Immunity·N C ChenH A Gaafar
Jun 1, 1975·The Journal of Experimental Medicine·T M Buchanan
May 1, 1976·Infection and Immunity·T M Buchanan, W A Pearce
Jul 1, 1974·Journal of Bacteriology·K H Johnston, E C Gotschlich
Jun 1, 1971·Annals of Internal Medicine·K K HolmesH N Beaty
Mar 1, 1980·Journal of Bacteriology·R L McDade, K H Johnston
Sep 1, 1963·Proceedings of the National Academy of Sciences of the United States of America·M J OSBORN
Oct 1, 1963·The Biochemical Journal·F C GREENWOODJ S GLOVER

❮ Previous
Next ❯

Citations

Apr 1, 1987·Genitourinary Medicine·C G Copley, S I Egglestone
Apr 1, 1984·Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section C, Immunology·T O Rød, J A Maeland
Apr 27, 2000·The Pediatric Infectious Disease Journal·F E BablE R Cooper
Nov 7, 2007·Infection and Immunity·Lisa A LewisPeter A Rice
Aug 1, 1989·Epidemiology and Infection·K M Bindayna, C A Ison
Aug 5, 2000·The Pediatric Infectious Disease Journal·B N Gomperts, L K White
Sep 10, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sarika AgarwalPeter A Rice
Mar 1, 1990·European Journal of Epidemiology·P K KohlD Petzoldt
Jun 27, 1985·The New England Journal of Medicine·B E BritiganP F Sparling
Feb 1, 1987·Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section B, Microbiology·L OdumJ S Knapp
Feb 1, 1997·Veterinary Microbiology·S M DaboG L Murphy
Nov 1, 1988·Journal of Clinical Microbiology·R E Hancock, L Chan
Mar 1, 1982·Infection and Immunity·D R VerstreateA J Winter
Jun 1, 1982·Infection and Immunity·M R TamR C Nowinski
Jun 1, 1997·Journal of Bacteriology·J SwansonD Kao
Oct 1, 1983·Infection and Immunity·C R MaliszewskiS J Badger
May 1, 1987·Infection and Immunity·G I Perez-Perez, M J Blaser

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.